Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0010629
|
negative regulation of gene expression |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,MYC, |
1.16E-4 |
GO:0048568
|
embryonic organ development |
SOX2,HOXB5,ZFPM2,ZEB1,MYC, |
1.54E-4 |
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter |
SOX2,TCF7L1,EP300,ZFPM2,ZEB1,MYC, |
2.70E-4 |
GO:0010604
|
positive regulation of macromolecule metabolic process |
SOX2,BCL2,TCF7L1,EP300,SHC1,ZFPM2,ZEB1,MYC, |
2.93E-4 |
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
SOX2,TCF7L1,EP300,SHC1,ZFPM2,ZEB1,MYC, |
3.72E-4 |
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process |
SOX2,TCF7L1,EP300,SHC1,ZFPM2,ZEB1,MYC, |
4.40E-4 |
GO:0010557
|
positive regulation of macromolecule biosynthetic process |
SOX2,TCF7L1,EP300,SHC1,ZFPM2,ZEB1,MYC, |
4.78E-4 |
GO:0031328
|
positive regulation of cellular biosynthetic process |
SOX2,TCF7L1,EP300,SHC1,ZFPM2,ZEB1,MYC, |
6.12E-4 |
GO:0009891
|
positive regulation of biosynthetic process |
SOX2,TCF7L1,EP300,SHC1,ZFPM2,ZEB1,MYC, |
6.61E-4 |
GO:0016481
|
negative regulation of transcription |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1, |
7.17E-4 |
GO:0007389
|
pattern specification process |
TCF7L1,HOXB5,EP300,ZEB2,ZEB1, |
8.19E-4 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
SOX2,KLF11,TCF7L1,EP300,ZFPM2,ZEB1,MYC, |
8.38E-4 |
GO:0045893
|
positive regulation of transcription, DNA-dependent |
SOX2,TCF7L1,EP300,ZFPM2,ZEB1,MYC, |
8.54E-4 |
GO:0010605
|
negative regulation of macromolecule metabolic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,MYC, |
8.81E-4 |
GO:0051254
|
positive regulation of RNA metabolic process |
SOX2,TCF7L1,EP300,ZFPM2,ZEB1,MYC, |
8.87E-4 |
GO:0006355
|
regulation of transcription, DNA-dependent |
SOX2,KLF11,TCF7L1,HOXB5,EP300,RERE,ZFPM2,ZEB2,ZEB1,MYC, |
1.11E-2 |
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1, |
1.17E-2 |
GO:0048562
|
embryonic organ morphogenesis |
SOX2,HOXB5,ZEB1,MYC, |
1.24E-2 |
GO:0051172
|
negative regulation of nitrogen compound metabolic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1, |
1.24E-2 |
GO:0042127
|
regulation of cell proliferation |
SOX2,BCL2,BAP1,KLF11,SHC1,ZEB1,MYC, |
1.26E-2 |
GO:0051252
|
regulation of RNA metabolic process |
SOX2,KLF11,TCF7L1,HOXB5,EP300,RERE,ZFPM2,ZEB2,ZEB1,MYC, |
1.31E-2 |
GO:0048598
|
embryonic morphogenesis |
SOX2,HOXB5,ZEB2,ZEB1,MYC, |
1.37E-2 |
GO:0009952
|
anterior/posterior pattern formation |
TCF7L1,HOXB5,EP300,ZEB2, |
1.44E-2 |
GO:0010558
|
negative regulation of macromolecule biosynthetic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1, |
1.57E-2 |
GO:0001501
|
skeletal system development |
BCL2,OSTF1,HOXB5,ZEB1,MYC, |
1.58E-2 |
GO:0031327
|
negative regulation of cellular biosynthetic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1, |
1.76E-2 |
GO:0045941
|
positive regulation of transcription |
SOX2,TCF7L1,EP300,ZFPM2,ZEB1,MYC, |
1.80E-2 |
GO:0043009
|
chordate embryonic development |
HOXB5,EP300,ZFPM2,ZEB2,ZEB1, |
1.81E-2 |
GO:0009792
|
embryonic development ending in birth or egg hatching |
HOXB5,EP300,ZFPM2,ZEB2,ZEB1, |
1.87E-2 |
GO:0009890
|
negative regulation of biosynthetic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1, |
1.93E-2 |
GO:0010628
|
positive regulation of gene expression |
SOX2,TCF7L1,EP300,ZFPM2,ZEB1,MYC, |
2.05E-2 |
GO:0045892
|
negative regulation of transcription, DNA-dependent |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB1, |
2.36E-2 |
GO:0006915
|
apoptosis |
BCL2,ELMO2,KLF11,EP300,XIAP,MYC, |
2.40E-2 |
GO:0030111
|
regulation of Wnt receptor signaling pathway |
SOX2,TCF7L1,ZEB2, |
2.50E-2 |
GO:0051253
|
negative regulation of RNA metabolic process |
SOX2,KLF11,TCF7L1,ZFPM2,ZEB1, |
2.51E-2 |
GO:0012501
|
programmed cell death |
BCL2,ELMO2,KLF11,EP300,XIAP,MYC, |
2.56E-2 |
GO:0035282
|
segmentation |
TCF7L1,EP300,ZEB2, |
2.72E-2 |
GO:0006350
|
transcription |
SOX2,KLF11,TCF7L1,HOXB5,EP300,RERE,ZFPM2,ZEB2,ZEB1,MYC, |
3.74E-2 |
GO:0003002
|
regionalization |
TCF7L1,HOXB5,EP300,ZEB2, |
3.81E-2 |
GO:0008219
|
cell death |
BCL2,ELMO2,KLF11,EP300,XIAP,MYC, |
5.17E-2 |
GO:0035295
|
tube development |
BCL2,EP300,ZFPM2,ZEB2, |
5.20E-2 |
GO:0016265
|
death |
BCL2,ELMO2,KLF11,EP300,XIAP,MYC, |
5.32E-2 |
GO:0007423
|
sensory organ development |
SOX2,BCL2,ZEB1,MYC, |
5.81E-2 |
GO:0007049
|
cell cycle |
SEPT7,BCL2,ERBB2IP,EP300,MYC,RASSF2, |
7.13E-2 |
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter |
SOX2,KLF11,ZFPM2,ZEB1, |
8.77E-2 |
|
|
|
|
|
|